NIH-funded research R21 grant

A blood protein test to quickly diagnose melioidosis

Official title: A plasma proteomic diagnostic for melioidosis

Funded at University of Washington · NIH-11618813 · Data updated 2026-11-12

A new plasma protein test aims to rapidly identify melioidosis in people admitted with infection, helping doctors start the right treatment sooner.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startSeptember 23, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$8,208
NIH project number3R21AI186381-02S2
Project IDNIH-11618813 on NIH RePORTER

Who could benefit from this research

Could help

Patients hospitalized with suspected infection in melioidosis-endemic regions (e.g., parts of Southeast Asia) where culture facilities are limited.

Less likely to help

Patients with non-melioidosis infections or without infection might not benefit from this diagnostic signature.

What this research studies

This project focuses on a blood-based diagnostic using a small panel of eight proteins found in plasma to tell melioidosis apart from other infections. It builds on previous work in a well-characterized patient group and uses samples collected during hospitalization to test the diagnostic signature. The team will analyze how well these protein markers distinguish melioidosis in real-world, resource-limited settings where cultures may be slow or unavailable. If successful, the test could provide a faster, non-culture method to guide treatment decisions and improve outcomes for patients with suspected infection due to Burkholderia pseudomallei.

Why it matters

Potential benefit: If the test works well, patients with melioidosis could receive faster, appropriate therapy, potentially reducing deaths.

How similar studies have gone: Preliminary studies showed high accuracy of the eight-protein signature in distinguishing melioidosis from other infections.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: West, Timothy Eoin — University of Washington
  • Study coordinator: West, Timothy Eoin

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.